Clinical trials
Dizziness trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 9 |
| Withdrawn | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Suspended | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins University | 7 |
| Otolith Labs | 5 |
| Massachusetts Eye and Ear Infirmary | 3 |
| BlueHalo | 2 |
| University of Miami | 2 |
| University of Montana | 2 |
| University of Wisconsin, Madison | 2 |
| VA Office of Research and Development | 2 |
| Walsh University | 2 |
| AdventHealth | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dizziness | 49 |
| Vertigo | 16 |
| Vestibular Diseases | 14 |
| Brain Concussion | 10 |
| Bilateral Vestibulopathy | 5 |
| Headache | 5 |
| Labyrinth Diseases | 5 |
| Motion Sickness | 4 |
| Ototoxicity | 4 |
| Sensation Disorders | 4 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.